Urovant Sciences Ltd.: key financial figures for fiscal year 2019 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Net Income/Loss (FY2019)
- -$146.7M
- Total Assets (FY2019)
- $63.3M
- Total Equity (FY2019)
- -$58.0M
- Cash Flows from Operating Activities (FY2019)
- -$102.1M
Source: Urovant Sciences Ltd. 10-K filing (FY2019). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
